Status:
UNKNOWN
Etodalac, Etoricoxib and Dexamethasone for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Trismus
Edema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether Etodalac, Etoricoxib and Dexamethasone are effective for Prevention of Pain ,Swelling and Trismus Following Third Molar Surgery
Eligibility Criteria
Inclusion
- Patients who are refered for third molar extraction to our center
- Must be able to swallow tablets
Exclusion
- Diabetes mellitus
- Thyroid diseases
- Cardiovascular diseases
- renal diseases
- hepatic diseases
- respiratory system diseases
- adrenal diseases
- Allergy to Etodalac, Etoricoxib or Dexamethasone
- Gastric ulcers
- psychiatric diseases
- Pregnant or breast feeding womans
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00793052
Start Date
November 1 2008
End Date
December 1 2009
Last Update
November 19 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.